 Carcinoma, Endometrioid
"Carcinoma, Endometrioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
| Descriptor ID |
D018269
|
| MeSH Number(s) |
C04.557.470.200.025.240 C04.588.945.418.948.585.124 C13.351.500.056.630.705.331 C13.351.937.418.685.331 C13.351.937.418.875.200.124 C19.391.630.705.331
|
| Concept/Terms |
Carcinoma, Endometrioid- Carcinoma, Endometrioid
- Carcinomas, Endometrioid
- Endometrioid Carcinoma
- Endometrioid Carcinomas
Adenocarcinoma, Endometrioid- Adenocarcinoma, Endometrioid
- Adenocarcinomas, Endometrioid
- Endometrioid Adenocarcinomas
- Endometrioid Adenocarcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Endometrioid".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Neoplasms by Site [C04.588]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Uterine Neoplasms [C04.588.945.418.948]
- Endometrial Neoplasms [C04.588.945.418.948.585]
- Carcinoma, Endometrioid [C04.588.945.418.948.585.124]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Genital Diseases, Female [C13.351.500]
- Adnexal Diseases [C13.351.500.056]
- Ovarian Diseases [C13.351.500.056.630]
- Ovarian Neoplasms [C13.351.500.056.630.705]
- Carcinoma, Endometrioid [C13.351.500.056.630.705.331]
- Urogenital Neoplasms [C13.351.937]
- Genital Neoplasms, Female [C13.351.937.418]
- Ovarian Neoplasms [C13.351.937.418.685]
- Carcinoma, Endometrioid [C13.351.937.418.685.331]
- Uterine Neoplasms [C13.351.937.418.875]
- Endometrial Neoplasms [C13.351.937.418.875.200]
- Carcinoma, Endometrioid [C13.351.937.418.875.200.124]
- Endocrine System Diseases [C19]
- Gonadal Disorders [C19.391]
- Ovarian Diseases [C19.391.630]
- Ovarian Neoplasms [C19.391.630.705]
- Carcinoma, Endometrioid [C19.391.630.705.331]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Endometrioid".
This graph shows the total number of publications written about "Carcinoma, Endometrioid" by people in UAMS Profiles by year, and whether "Carcinoma, Endometrioid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2019 | 2 | 1 | 3 | | 2018 | 1 | 0 | 1 | | 2017 | 3 | 0 | 3 | | 2016 | 1 | 0 | 1 | | 2014 | 2 | 2 | 4 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 1 | 2 | | 2010 | 3 | 1 | 4 | | 2009 | 2 | 0 | 2 | | 2007 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2005 | 1 | 2 | 3 | | 2002 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Endometrioid" by people in Profiles over the past ten years.
-
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecol Oncol. 2023 09; 176:16-24.
-
Wright MF, Fitzlaff S, Wyeth A, Zaragoza-Watkins M, Podoll MB, Quick CM, Watkins JC. Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy. Int J Gynecol Pathol. 2021 May 01; 40(3):240-247.
-
Son J, Chambers LM, Carr C, Michener CM, Yao M, Beavis A, Yen TT, Stone RL, Wethington SL, Fader AN, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan A, Ricci S. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion. Int J Gynecol Cancer. 2020 11; 30(11):1738-1747.
-
Beavis AL, Yen TT, Stone RL, Wethington SL, Carr C, Son J, Chambers L, Michener CM, Ricci S, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan AN, Jager LR, Fader AN. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? Gynecol Oncol. 2020 03; 156(3):568-574.
-
Krill L, Deng W, Eskander R, Mutch D, Zweizig S, Hoang B, Ioffe O, Randall L, Lankes H, Miller DS, Birrer M. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2020 02; 156(2):423-429.
-
Mirza MR, ?vall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, ?r Knudsen A, Staff S, Krog Vistisen A, Bj?rge L, M?enp?? JU. Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial. Lancet Oncol. 2019 10; 20(10):1409-1419.
-
Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019 10; 155(1):39-50.
-
Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, Soliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers. Gynecol Oncol. 2018 03; 148(3):480-484.
-
Devor EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, Lankes HA, Thaker P, Argenta PA, Pearl ML, Zweizig SL, Mannel RS, Brown A, Ramirez NC, Ioffe OB, Park KJ, Creasman WT, Birrer MJ, Mutch D, Leslie KK. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653.
-
Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol. 2017 08; 130(2):403-410.
-
Reyes HD, Miecznikowski J, Gonzalez-Bosquet J, Devor EJ, Zhang Y, Thiel KW, Samuelson MI, McDonald M, Stephan JM, Hanjani P, Guntupalli S, Tewari KS, Backes F, Ramirez N, Fleming GF, Filiaci V, Birrer MJ, Leslie KK. High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. Gynecol Oncol. 2017 08; 146(2):247-253.
-
Dizon DS, Birrer MJ. Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus. J Natl Cancer Inst. 2016 Jun; 108(6):djv442.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|